1970)
4. R Buttiaux, M. Catsaras, L'analyse bactériologigue de bières, Ann. Inst. Pasteur, 16, 167 (1965)
5. H. Modde, Klinisch-bakteriologische Aspekte der Gentamicintherapie, Therap. Umschau, Suppl.
et al., J. Biol. Chem., 246, 7675, (1971).
22. Silverstein, R.M. and Kezdy, F.J., Arch. Biochem. Biophys., 167, 678, (1975).
23. Glover, G. and Shaw, E., J. Biol. Chem., 246, 4594, (1971).
24. Levy
and enteropathogenic halophilic
vibrios, 9, 246 (1963)
5. R Buttiaux, M. Catsaras, L'analyse bactériologigue de bières, Ann. Inst. Pasteur, 16, 167 (1965)
6. H. Modde, Klinisch-bakteriologische
Microbiology.
8. Cotton, M., Baker, A., Saltik, M., Wagner, E. and Buschle, M. (1994) Gene Ther. 1, 239-246.
9. Hendriks, R., Wehsling, M., Lantos, A., Berg, J. and McCormick, M. (2000) inNovations 11, 1-3
with diaphragm Apura® 109255 167
CombiCoulomat fritless Karl Fischer reagent for coulometric water determination for cells with and without diaphragm Apura® 109257 167
CombiMethanol solvent for volumetric
coexpressed in E. coli (10).
Regions of E2F-1, E2F-2, E2F-3, DP-1,
and DP-2 that encode 181, 184, 183, 246,
and 249 amino acids, respectively, were
amplified from plasmid templates. Six
ENHANCED PROTEIN
E2F2 E8776 M y n/d n/d
243 E2F3 E8651 M y n/d n/d
244 E2F4 E8526 M y n/d n/d
245 E6AP E8655 M y y y
246 EGF receptor E3138 M y n/d n/d
247 ERK5 (Big MAPK-BMK1) E1523 P y y n/d
248